Results 191 to 198 of about 24,579 (198)
Some of the next articles are maybe not open access.
Chronic neonatal MK-801 treatment increases MK-801-induced hyperlocomotion in adulthood
Neuroscience Research, 2011Hiroki Furuie +3 more
openaire +1 more source
Possible abuse potential of the NMDA antagonist MK-801
Behavioural Brain Research, 1989Selective antagonists of the N-methyl-D-aspartate (NMDA) receptor such as MK-801 may have therapeutic potential in the treatment of ischemic brain injury. However, some drugs (e.g. ketamine and phencyclidine) with potent NMDA antagonist properties are also addictive.
openaire +2 more sources
Neurocytotoxicity of phencyclidine and MK-801
Biological Psychiatry, 1989John W. Olney +2 more
openaire +1 more source
MK-801 subsensitivity following postweaning lead exposure.
Neurotoxicology, 1995This study sought to determine whether the reported lead-induced inhibition of binding of the non-competitive NMDA receptor complex antagonist, MK-801, was of sufficient biological strength and relevance to produce changes in MK-801 behavioral sensitivity.
openaire +1 more source
MK 801: A Possible Neuroprotective Agent by Poststroke Depression?
Journal of Neuropsychiatry, 2008Ozan, Erol, Yulug, Burak, Cam, Ertugrul
openaire +4 more sources
MK-801 MEDIATES LOCOMOTION VIA DOPAMINERGIC NEURONS
Behavioural Pharmacology, 1995U O KRONTHALER, M BUBSER, W J SCHMIDT
openaire +1 more source
MK-801 inhibits morphine conditioned place preference
Pharmacological Research, 1992openaire +1 more source
(+) MK-801 PREVENTS DIETHYLDITHIOCARBAMATE-INDUCED NEURONAL DAMAGE
1993VAGLINI, FRANCESCA +3 more
openaire +1 more source